Nanjing Sinolife United Reports Revenue Growth Amidst Declining Profits

An update from Nanjing Sinolife United Co., Ltd. Class H ( (HK:3332) ) is now available.

Nanjing Sinolife United Co., Ltd. reported a significant increase in revenue by 32.6% to RMB747.9 million for the year ending December 31, 2024, compared to the previous year. Despite the revenue growth and a 41.8% rise in gross profit, the company’s net profit decreased to RMB34.6 million from RMB52.6 million in 2023, attributed to higher selling and distribution expenses. The board decided not to recommend any final or special dividends for the year, reflecting a cautious approach amidst fluctuating profit margins.

More about Nanjing Sinolife United Co., Ltd. Class H

Nanjing Sinolife United Co., Ltd. is a joint stock limited liability company incorporated in China, operating within the health and wellness industry. The company primarily focuses on the production and distribution of nutritional supplements and health-related products, catering to a growing market demand for wellness and preventive healthcare solutions.

YTD Price Performance: -7.41%

Average Trading Volume: 131,513

Technical Sentiment Signal: Sell

Current Market Cap: HK$810.1M

For a thorough assessment of 3332 stock, go to TipRanks’ Stock Analysis page.